Steven Cohen's VYGR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 268,223 shares of Voyager Therapeutics, Inc. (VYGR) worth $1.04 M, representing 0.00% of the portfolio. First purchased in 2017-Q3, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in VYGR, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2022, adding 289,420 shares. Largest reduction occurred in Q4 2022, reducing 289,420 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Voyager Therapeutics (VYGR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Voyager Therapeutics (VYGR) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +172,872 | Add 181.30% | 268,223 | $3.86 |
| Q4 2025 | +95,351 | New Buy | 95,351 | $3.93 |
| Q1 2025 | -1,182 | Sold Out | 0 | $0.00 |
| Q4 2024 | +1,182 | New Buy | 1,182 | $5.67 |
| Q2 2023 | -6,224 | Sold Out | 0 | $0.00 |
| Q1 2023 | +6,224 | New Buy | 6,224 | $7.71 |
| Q4 2022 | -289,420 | Sold Out | 0 | $0.00 |
| Q3 2022 | +289,420 | New Buy | 289,420 | $5.92 |
| Q4 2018 | -101,975 | Sold Out | 0 | $0.00 |
| Q3 2018 | +101,975 | New Buy | 101,975 | $18.92 |
| Q4 2017 | -130,900 | Sold Out | 0 | $0.00 |
| Q3 2017 | +130,900 | New Buy | 130,900 | $20.59 |
Steven Cohen's Voyager Therapeutics Investment FAQs
Steven Cohen first purchased Voyager Therapeutics, Inc. (VYGR) in Q3 2017, acquiring 130,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Voyager Therapeutics, Inc. (VYGR) for 12 quarters since Q3 2017.
Steven Cohen's largest addition to Voyager Therapeutics, Inc. (VYGR) was in Q3 2022, adding 289,420 shares worth $1.71 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 268,223 shares of Voyager Therapeutics, Inc. (VYGR), valued at approximately $1.04 M.
As of the Q1 2026 filing, Voyager Therapeutics, Inc. (VYGR) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Voyager Therapeutics, Inc. (VYGR) was 289,420 shares, as reported at the end of Q3 2022.